AMA Pushes Congress to Regulate AI Therapy Chatbots as Mental Health Risk Grows
The AMA is urging Congress to regulate mental health chatbots, reflecting growing concern about AI systems that blur the line between support and therapy. The debate highlights a fast-moving policy gap in a category where errors can have serious clinical consequences.
Mental health chatbots are one of the clearest examples of healthcare AI moving faster than its governance. The AMA’s call for congressional action suggests the professional community no longer sees this as a niche consumer-tech issue, but as a patient safety and scope-of-practice problem.
The challenge is that these tools often occupy a gray zone. They may offer emotional support, coaching, screening, or guidance, yet the user experience can feel therapeutic even when the system has no clinical accountability. That mismatch creates risk, especially for vulnerable users who may not distinguish between conversational familiarity and actual care.
Regulation here will not be simple. Policymakers have to decide whether to focus on claims, use cases, disclosure, escalation protocols, data handling, or clinical validation. Each approach has tradeoffs, but the absence of guardrails is increasingly hard to defend when these tools are being used for sensitive mental health support.
This story matters beyond chatbots. It is an early test of how regulators will treat AI systems that look and feel like care but are not licensed care. The outcome could shape broader rules for consumer-facing AI across healthcare.